Opiant Pharmaceuticals Investor Relations Material
Latest events
Q2 2022
Opiant Pharmaceuticals
Investor Presentation
16 Feb, 2023
Q4 2022
16 Feb, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Opiant Pharmaceuticals Inc
Access all reports
Opiant Pharmaceuticals Inc. specialized in the development of treatments for addiction and drug overdose. The company focused on advancing pharmaceutical therapies based on proprietary formulations and delivery methods. Its work involved both research and regulatory development activities. The company was headquartered in Santa Monica, California, and its shares were listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
OPNT
Country
🇺🇸 United States